Cleared Traditional

K140175 - INTRAVASCULAR ADMINISTRATION SET

K140175 is the FDA 510(k) clearance for INTRAVASCULAR ADMINISTRATION SET by Delta Med Spa. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 194-day FDA review.

K140175 · Delta Med Spa · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
194d
Days
Class 2
Risk

K140175 is an FDA 510(k) clearance for the INTRAVASCULAR ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Delta Med Spa (Rome, IT). The FDA issued a Cleared decision on August 5, 2014 after a review of 194 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Delta Med Spa devices

Submission Details

510(k) Number K140175 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2014
Decision Date August 05, 2014
Days to Decision 194 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
65d slower than avg
Panel avg: 129d · This submission: 194d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 449
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K140175.
MaxZero Administration Sets
K143234 · Care Fusion · Nov 2014
INFUSOMAT SPACE VOLUMETRIC INFUSION PUMP ADMINISTRATION SETS
K142036 · B.Braun Medical, Inc. · Aug 2014
SOLUTION SET/EXTENSION SET
K142011 · Baxter Healthcare Corporation · Aug 2014
CARESITE LUER ACCESS DEVICE
K140311 · B.Braun Medical, Inc. · May 2014
MAXZERO EXTENSION SET WITH NEEDLESS CONNECTOR
K140831 · Care Fusion · Apr 2014
MEDCOMP POWER INJECTABLE SAFETY HUBER NEEDLE
K132880 · Medical Components, Inc. · Jan 2014